• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[诊断测试:优点、特征与解读:在新冠疫情及不同的严重急性呼吸综合征冠状病毒2检测的影响下]

[The Diagnostic Test: Goodness, Characteristics, and Interpretation: Under the Impact of the Corona Pandemic and Different SARS-CoV-2 Tests].

作者信息

Röhrig Bernd

出版信息

Gesundheitswesen. 2023 Jun;85(6):578-594. doi: 10.1055/a-1937-9516. Epub 2023 Feb 27.

DOI:10.1055/a-1937-9516
PMID:36848945
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11248145/
Abstract

INTRODUCTION

Many diagnostic tests are currently being performed around the world to detect SARS-CoV-2 infection. Positive and negative test results are not one hundred percent accurate, but have far-reaching consequences. There are false positives (test positive, uninfected) and false negatives (test negative, infected). A positive/negative result does not necessarily mean that the test subject is actually infected/non-infected. This article has two objectives: 1. to explain the most important characteristics of diagnostic tests with binary outcome 2. to point out problems and phenomena of interpretation of diagnostic tests, on the basis of different scenarios.

METHOD

Presentation of the basic concepts of the quality of a diagnostic test (sensitivity, specificity) and pre-test probability (prevalence of test group). Calculation (including formulas) of further important quantities.

RESULTS

In the basic scenario, sensitivity is 100%, specificity 98.8%, and pre-test probability of 1.0% (10 infected persons per 1,000 tested). For 1,000 diagnostic tests, the statistical mean is 22 positive cases, 10 of which are true-positive. The positive predictive probability is 45.7%. The prevalence calculated from this (22/1,000 tests) overestimates the actual prevalence (10/1,000 tests) by a factor of 2.2. All cases with a negative test outcome are true negative. The prevalence has a strong influence on the positive and negative predictive value. This phenomenon occurs even with otherwise very good test values of sensitivity and specificity. At a prevalence of only 5 infected persons per 10,000 (0.05%), the positive predictive probability drops to 4.0%. Lower specificity amplifies this effect, especially with small numbers of infected persons.

CONCLUSION

If the sensitivity or specificity is below 100%, diagnostic tests are always error-prone. If the prevalence of infected persons is low, a large number of false positive results are to be expected - even if the test is of good quality with a high sensitivity and especially a high specificity. This is accompanied by low positive predictive values, i. e. positive tested persons are not infected. A false positive test result in the first test can be clarified by carrying out a second test.

摘要

引言

目前全球正在进行许多诊断测试以检测新型冠状病毒感染。阳性和阴性测试结果并非百分之百准确,但却有着深远影响。存在假阳性(测试呈阳性但未感染)和假阴性(测试呈阴性但已感染)情况。阳性/阴性结果并不一定意味着受测者实际已感染/未感染。本文有两个目标:1. 解释二元结果诊断测试的最重要特征;2. 根据不同场景指出诊断测试解释中的问题和现象。

方法

介绍诊断测试质量的基本概念(敏感性、特异性)和预测试概率(测试组患病率)。计算(包括公式)其他重要量值。

结果

在基本场景中,敏感性为100%,特异性为98.8%,预测试概率为1.0%(每1000名受测者中有10名感染者)。对于1000次诊断测试,统计平均值为22例阳性病例,其中10例为真阳性。阳性预测概率为45.7%。据此计算出的患病率(22/1000次测试)高估了实际患病率(10/1000次测试)2.2倍。所有测试结果为阴性的病例均为真阴性。患病率对阳性和阴性预测值有很大影响。即使敏感性和特异性测试值在其他方面非常好,这种现象也会出现。当每10000人中只有5名感染者(0.05%)时,阳性预测概率降至4.0%。较低的特异性会放大这种影响,尤其是在感染者数量较少时。

结论

如果敏感性或特异性低于100%,诊断测试总是容易出错。如果感染者患病率较低,即使测试质量良好,敏感性高尤其是特异性高,也会出现大量假阳性结果。这伴随着较低的阳性预测值,即测试呈阳性的人未被感染。首次测试中的假阳性结果可通过进行第二次测试来澄清。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/465d/11248145/d778e464f0bd/10-1055-a-1937-9516-i2021-12-1565-0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/465d/11248145/d778e464f0bd/10-1055-a-1937-9516-i2021-12-1565-0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/465d/11248145/d778e464f0bd/10-1055-a-1937-9516-i2021-12-1565-0002.jpg

相似文献

1
[The Diagnostic Test: Goodness, Characteristics, and Interpretation: Under the Impact of the Corona Pandemic and Different SARS-CoV-2 Tests].[诊断测试:优点、特征与解读:在新冠疫情及不同的严重急性呼吸综合征冠状病毒2检测的影响下]
Gesundheitswesen. 2023 Jun;85(6):578-594. doi: 10.1055/a-1937-9516. Epub 2023 Feb 27.
2
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
3
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.在普通人群中进行 SARS-CoV-2 监测的四种不同策略的有效性和成本效益(CoV-Surv 研究):一项关于集群随机、双因素对照试验的研究方案的结构化总结。
Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z.
4
Universal screening for SARS-CoV-2 infection: a rapid review.SARS-CoV-2 感染的普遍筛查:快速综述。
Cochrane Database Syst Rev. 2020 Sep 15;9(9):CD013718. doi: 10.1002/14651858.CD013718.
5
[Antibody tests for COVID-19: What the results tell us].[新冠病毒抗体检测:结果能告诉我们什么]
Z Evid Fortbild Qual Gesundhwes. 2020 Aug;153:54-59. doi: 10.1016/j.zefq.2020.05.005. Epub 2020 May 15.
6
The risk of over-diagnosis in serological testing. Implications for communications strategies.血清学检测的过度诊断风险。对沟通策略的影响。
Epidemiol Prev. 2020 Sep-Dec;44(5-6 Suppl 2):184-192. doi: 10.19191/EP20.5-6.S2.117.
7
Authors' response: Occupation and SARS-CoV-2 infection risk among workers during the first pandemic wave in Germany: potential for bias.作者回复:在德国首次大流行期间,工人的职业与 SARS-CoV-2 感染风险:潜在的偏见。
Scand J Work Environ Health. 2022 Sep 1;48(7):588-590. doi: 10.5271/sjweh.4061. Epub 2022 Sep 25.
8
A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.一项前瞻性、随机、单盲、交叉试验,旨在研究可穿戴设备对远程早期检测 SARS-CoV-2 感染(COVID-RED)的影响:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jun 22;22(1):412. doi: 10.1186/s13063-021-05241-5.
9
Estimating the false-negative test probability of SARS-CoV-2 by RT-PCR.估算 RT-PCR 检测 SARS-CoV-2 的假阴性率。
Euro Surveill. 2020 Dec;25(50). doi: 10.2807/1560-7917.ES.2020.25.50.2000568.
10
A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.一项前瞻性、随机、单盲、交叉试验,旨在研究可穿戴设备对 SARS-CoV-2 感染(COVID-RED)的远程早期检测的影响:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Oct 11;22(1):694. doi: 10.1186/s13063-021-05643-5.

引用本文的文献

1
A unified framework for diagnostic test development and evaluation during outbreaks of emerging infections.新发传染病暴发期间诊断检测开发与评估的统一框架。
Commun Med (Lond). 2024 Dec 10;4(1):263. doi: 10.1038/s43856-024-00691-9.

本文引用的文献

1
Comparative sensitivity evaluation for 122 CE-marked rapid diagnostic tests for SARS-CoV-2 antigen, Germany, September 2020 to April 2021.2020 年 9 月至 2021 年 4 月德国对 122 种经 CE 标记的 SARS-CoV-2 抗原快速诊断检测试剂的比较敏感性评估。
Euro Surveill. 2021 Nov;26(44). doi: 10.2807/1560-7917.ES.2021.26.44.2100441.
2
Diagnostic accuracy of a SARS-CoV-2 rapid antigen test in real-life clinical settings.在真实临床环境中 SARS-CoV-2 快速抗原检测的诊断准确性。
Int J Infect Dis. 2021 Aug;109:118-122. doi: 10.1016/j.ijid.2021.07.010. Epub 2021 Jul 7.
3
Clinical performance evaluation of SARS-CoV-2 rapid antigen testing in point of care usage in comparison to RT-qPCR.
即时检测点使用与 RT-qPCR 相比的 SARS-CoV-2 快速抗原检测的临床性能评估。
EBioMedicine. 2021 Jul;69:103455. doi: 10.1016/j.ebiom.2021.103455. Epub 2021 Jun 26.
4
[Strategy for a Risk-stratified Use of Rapid Antigen Testing: Containing the SARS-CoV-2 Pandemic by Integrating Rapid Testing into Case and Contact Tracing Management].
Gesundheitswesen. 2021 May;83(5):349-353. doi: 10.1055/a-1408-3885. Epub 2021 Apr 8.
5
False-positive COVID-19 results: hidden problems and costs.新冠病毒检测假阳性结果:潜在问题与成本
Lancet Respir Med. 2020 Dec;8(12):1167-1168. doi: 10.1016/S2213-2600(20)30453-7. Epub 2020 Sep 29.
6
Covid-19 mass testing programmes.新冠病毒-19大规模检测计划
BMJ. 2020 Aug 20;370:m3262. doi: 10.1136/bmj.m3262.
7
[Not Available].[无可用内容]。
Gesundheitswesen. 2020 Jul;82(7):575-577. doi: 10.1055/a-1195-0143. Epub 2020 Jul 22.
8
False Negative Tests for SARS-CoV-2 Infection - Challenges and Implications.新型冠状病毒2型感染的假阴性检测——挑战与影响
N Engl J Med. 2020 Aug 6;383(6):e38. doi: 10.1056/NEJMp2015897. Epub 2020 Jun 5.
9
Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction-Based SARS-CoV-2 Tests by Time Since Exposure.基于时间的暴露后,逆转录聚合酶链反应(RT-PCR)检测 SARS-CoV-2 的假阴性率的变化。
Ann Intern Med. 2020 Aug 18;173(4):262-267. doi: 10.7326/M20-1495. Epub 2020 May 13.
10
Interpreting a covid-19 test result.解读新冠病毒检测结果。
BMJ. 2020 May 12;369:m1808. doi: 10.1136/bmj.m1808.